BOSTON, Sept. 21, 2020 /PRNewswire/ — An update of “Registries for Evaluating Patient Outcomes: A User’s Guide: 4th Edition,” was released today, the fourth edition of a reference handbook from the U.S. Agency for Healthcare Research and Quality (AHRQ) that contains practical information on the design, operation, and analysis of patient registries. First published in 2007, the User’s Guide is among the most cited texts on the subject of patient registries.
The 4th edition of the User’s Guide was produced by OM1 under contract to AHRQ and L&M Policy Research, and led by OM1’s Dr. Richard Gliklich, CEO, and Michelle Leavy, head of Healthcare Research & Policy. This version is a streamlined edition that combines updates to the existing chapters with new chapters addressing innovations in patient registry design. The 4th edition supersedes previous versions.
The 4th edition:
- Features 14 chapters focusing on the fundamentals of registry planning, design, operations, analysis, and evaluation
- Considers the trend toward incorporating data from multiple sources into registries
- Provides updated content across all chapters to reflect the issues related to use of different data sources
- Addresses the revised Common Rule and its implications for registries
- Includes two new chapters – one on the selection and definition of outcomes for patient registries and one on registry governance
- Incorporates content from earlier eBooks on developing patient-centered registries, engaging patients in registry development and operations, and incorporating new tools to support interoperability and exchange of data with other sources
“Registries are one of the key sources for real-world data and evidence to meet a variety of needs for multiple stakeholders,” said Leavy. “This new edition provides practical information to support the development and management of high-quality registries and related sources of real-world data.”
AHRQ, part of the U.S. Department of Health and Human Services (HHS), is the nation’s lead health services research and patient safety agency. Its mission is to produce evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable, and to work within HHS and with other partners to make sure that the evidence is understood and used.
Head of Marketing, OM1
OM1 is a health outcomes, registries, and technology company leveraging big clinical data and AI to better understand, compare, and predict patient outcomes. OM1’s real world evidence platform, clinical registries and AI technologies enable clients to accelerate research, measure and benchmark health outcomes and to personalize patient care. Learn more at www.om1.com.